EGATEN

This brand name is authorized in France, United States

Active ingredients

The drug EGATEN contains one active pharmaceutical ingredient (API):

1 Triclabendazole UNII 4784C8E03O - TRICLABENDAZOLE

Triclabendazole is an anthelmintic against Fasciola species, used for the treatment of fascioliasis. Read about Triclabendazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EGATEN Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02BX04	Triclabendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BX Other antitrematodal agents
Discover more medicines within P02BX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 67258794
Country: US	FDA, National Drug Code	Identifier(s): 0078-0937